Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.56	5.25	19.14	14.46	34.48
Short-Term Investments	0	0	0	40.01	0
Cash & Cash Equivalents	2.56	5.25	19.14	54.47	34.48
Cash Growth	-51.26%	-72.60%	-64.86%	57.98%	339.17%
Receivables	3.39	3.38	1.53	0.87	0
Inventory	2.74	1.33	0.97	0	0
Other Current Assets	0.84	1.4	2.28	1.45	0.84
Total Current Assets	9.53	11.36	23.93	56.79	35.32
Property, Plant & Equipment	0.49	0.87	13.4	14.38	14.04
Other Long-Term Assets	0.24	2.01	2.01	1.9	0.18
Total Long-Term Assets	0.73	2.88	15.41	16.28	14.22
Total Assets	10.26	14.24	39.33	73.06	49.54
Accounts Payable	9.57	7.73	8.71	3.87	1.82
Current Debt	2.07	1.75	17.01	0.14	0.17
Other Current Liabilities	9.13	3.91	3.56	3.35	1.8
Total Current Liabilities	20.78	13.39	29.28	7.35	3.8
Long-Term Debt	0.1	0.47	0.78	16.38	0
Other Long-Term Liabilities	5.7	5.93	0	0	0
Total Long-Term Liabilities	5.8	6.4	0.78	16.38	0
Total Liabilities	26.57	19.79	30.06	23.73	3.8
Total Debt	2.17	2.21	17.79	16.52	0.17
Debt Growth	-1.76%	-87.57%	7.71%	9504.07%	-
Common Stock	0	0	0.01	0.01	0.01
Retained Earnings	-423.17	-408.7	-387.12	-312.22	-260.37
Comprehensive Income	0	0	0	0	0
Shareholders' Equity	-16.32	-5.55	9.27	49.33	45.75
Total Liabilities and Equity	10.26	14.24	39.33	73.06	49.54
Net Cash / Debt	0.39	3.04	1.35	37.95	34.31
Net Cash / Debt Growth	-87.31%	124.65%	-96.44%	10.62%	336.98%
Net Cash Per Share	0.18	7.02	1113.39	896.34	1388.05
Working Capital	-11.25	-2.03	-5.35	49.43	31.52
Book Value Per Share	-7.57	-12.83	7640.45	1165.02	1850.83

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.